Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
Cancer Science, 06/05/09
Shirakawa H et al. - In a study to determine the expression profile of glypican (GPC)-3 in association with clinicopathological factors in hepatocellular carcinoma (HCC) pts and investigate the potential prognostic value of GPC3 by comparing the survival rate between GPC3-positive and GPC3-negative HCC pts, it was shown that GPC3 expression is correlated with a poor prognosis in HCC pts.
Methods- Primary HCC tissue samples (n=107) obtained from pts who had undergone hepatectomy between 2000 and 2001 were analyzed.
- GPC3 expression was less frequently observed in well-differentiated HCC than in moderately and poorly differentiated HCC, the difference in the frequency being statistically significant.
- GPC3-positive HCC pts had a significantly lower 5-yr survival rate than the GPC3-negative HCC pts (54.5 vs 87.7%).
- Among 80 of 107 (74.6%) pts with initial treatment who underwent hepatectomy, none of GPC3-negative HCC pts (n=16, 20.0%) died during follow-up.
- No deaths were noted in the GPC3-negative HCC pts among the 71 (88.7%) pts with moderately and poorly differentiated HCC.
- Multivariate analysis identified GPC3 expression as an independent prognostic factor for overall survival.
Related Articles
Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Annals of Surgical Oncology, 11/11/09
Relevance Score: 69%
Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease
American Journal of Roentgenology, 10/09/09
Relevance Score: 69%
Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
World Journal of Gastroenterology, 10/27/09
Relevance Score: 68%
Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09
Relevance Score: 68%
MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09
Relevance Score: 68%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients
International Journal of Cancer, 12/15/09
BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer
International Journal of Cancer, 12/15/09
Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells
International Journal of Cancer, 12/15/09
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma
Carcinogenesis, 12/15/09
Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma
Cancer, 12/15/09
MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications
Cancer Letters, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


